Dan-Arin Silasi, MD
Assistant Professor
Yale University School of Medicine
333 Cedar St.
PO Box 208063
New Haven,
CT
USA
06520-3206
Papers:
140
Neratinib, an irreversible ErbB receptor tyrosine kinase inhibitor, shows efficacy in the treatment of HER2 amplified carcinosarcoma in vitro and in vivo
182
Cervical adenocarcinoma in situ: an institutional retrospective review of surgical management and outcome
262
Choice of adjuvant chemotherapy following neoadjuvant carboplatin/paclitaxel and delayed primary debulking
401
Mutations in the PIK3 pathway as a major determinant of trastuzumab resistance in uterine serous carcinoma
Robotic tumor debulking with bowel resection and anastomosis in a patient with stage IIIB fallopian tube carcinoma
Robotic upper vaginectomy for recurrent undifferentiated endometrial sarcoma